SLC9A3 and inflammatory bowel disease: Considering the importance of T-cell driven immune response to commensal bacteria in the pathogenesis of human IBD, we sought to address whether loss of NHE3 activity modulates gut microbiota and mucosal immune responses in a chronic, progressive, T cell mediated [32], and microbiota-dependent [33], model of colitis.